Expert consensus on vaccinations in adult patients with autoimmune rheumatic diseases in China (2023 Edition)

VernacularTitle:中国成人风湿免疫性疾病患者疫苗接种专家共识（2023版）
Keywords: Vaccinations; Adult; Autoimmune rheumatic diseases; Expert consensus
From: Chinese Journal of Preventive Medicine 2024;58(1):1-10
CountryChina
Language:Chinese
Abstract: Vaccination is one of the critical tools to prevent infections among individuals with autoimmune rheumatic diseases (ARDs), ultimately improving the quality of life and reducing mortality. The incorporation of vaccination strategies into clinical decision-making processes has been recognized as pivotal. However, the absence of clinical guidelines and consensus on vaccination for ARDs patients still persists in China. Drawing from existing clinical evidence, this expert consensus encompasses eight prevalent vaccines: Influenza vaccine, pneumococcal polysaccharide vaccine, COVID-19 vaccine, herpes zoster vaccine, human papillomavirus vaccine, hepatitis A vaccine, hepatitis B vaccine, and rabies virus vaccine. This initiative aims to furnish highly practical technical directives for vaccination personnel and rheumatologists, thereby fostering standardized vaccination practices to combat infectious diseases among adult ARDs patients in China.